Priscilla R Costa
Overview
Explore the profile of Priscilla R Costa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
456
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goncalves A, Costa P, Thomazella M, Correia C, Marmorato M, Dias J, et al.
J Med Virol
. 2024 Dec;
96(12):e70099.
PMID: 39639628
In the 2018 yellow fever (YF) outbreak in Brazil, we generated new transcriptomic data and combined it with clinical and immunological data to decode the pathogenesis of YF. Analyzing 79...
2.
van de Weg C, Thomazella M, Marmorato M, Correia C, Dias J, Maestri A, et al.
J Infect Dis
. 2024 Jul;
230(1):e60-e64.
PMID: 39052712
In 2018 there was a large yellow fever outbreak in São Paulo, Brazil, with a high fatality rate. Yellow fever virus can cause, among other symptoms, hemorrhage and disseminated intravascular...
3.
Avelino-Silva V, Thomazella M, Marmorato M, Correia C, Dias J, Maestri A, et al.
J Infect Dis
. 2022 Nov;
227(9):1097-1103.
PMID: 36316804
Background: Yellow fever is a mosquito-borne zoonotic disease caused by yellow fever virus (YFV). Between 2017 and 2019, more than 504 human cases and 176 deaths were confirmed in the...
4.
Silveira C, Magnani D, Costa P, Avelino-Silva V, Ricciardi M, Timenetsky M, et al.
Front Immunol
. 2022 Jul;
13:908398.
PMID: 35837409
An effective vaccine against the dengue virus (DENV) should induce a balanced, long-lasting antibody (Ab) response against all four viral serotypes. The burst of plasmablasts in the peripheral blood after...
5.
Silva G, Pereira-Manfro W, Costa P, Costa D, Ferreira B, Barreto D, et al.
Clinics (Sao Paulo)
. 2021 Oct;
76:e2902.
PMID: 34614112
Objectives: To investigate the expression levels of surface markers of activation (CD38 and HLA-DR), inhibition (PD-1, TIGIT and CD57) and co-stimulation (CD28 and CD127) on CD4+ T cells of children/adolescents...
6.
Narciso T, Hoshida M, Costa P, Niquirilo A, Biancolin S, Lin L, et al.
Fetal Diagn Ther
. 2021 Mar;
48(3):227-234.
PMID: 33706316
Objective: The objective of this study was to compare the frequency and percentage of fetal hemoglobin (HbF%) by flow cytometry of (1) first-trimester asymptomatic patients with intrauterine hematoma (IUH), (2)...
7.
Kallas E, Precioso A, Palacios R, Thome B, Braga P, Vanni T, et al.
Lancet Infect Dis
. 2020 Mar;
20(7):839-850.
PMID: 32220283
Background: The Butantan Institute has manufactured a lyophilised tetravalent live-attenuated dengue vaccine Butantan-DV, which is analogous to the US National Institutes of Health (NIH) TV003 admixture. We aimed to assess...
8.
Kallas E, DElia Zanella L, Moreira C, Buccheri R, Diniz G, Castineiras A, et al.
Lancet Infect Dis
. 2019 May;
19(7):750-758.
PMID: 31104909
Background: Yellow fever virus infection results in death in around 30% of symptomatic individuals. The aim of this study was to identify predictors of death measured at hospital admission in...
9.
Paquin-Proulx D, Costa P, Terrassani Silveira C, Marmorato M, Cerqueira N, Sutton M, et al.
Front Immunol
. 2018 Jul;
9:1394.
PMID: 29971068
Increasing drug resistance and the lack of an effective vaccine are the main factors contributing to (Mtb) being a major cause of death globally. Despite intensive research efforts, it is...
10.
Grifoni A, Angelo M, Lopez B, ORourke P, Sidney J, Cerpas C, et al.
Front Immunol
. 2017 Oct;
8:1309.
PMID: 29081779
Background: Dengue is a major public health problem worldwide. Assessment of adaptive immunity is important to understanding immunopathology and to define correlates of protection against dengue virus (DENV). To enable...